"on small cell lung cancer" trang 3 - tải miễn phí từ tailieunhanh
Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues

Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues
17    77    1
Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: A critical review

Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: A critical review
9    55    1
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer

Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
15    48    1
Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer

Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer
6    48    1
The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer

The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer
9    30    1
Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression

Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression
9    76    1
Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer

Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer
10    36    1
Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer
8    34    1
Pattern of use of radiotherapy for lung cancer: A descriptive study

Pattern of use of radiotherapy for lung cancer: A descriptive study
8    42    1
Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer

Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer
7    34    1
Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines

Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines
9    47    1
Osteopontin is a prognostic biomarker in non-small cell lung cancer

Osteopontin is a prognostic biomarker in non-small cell lung cancer
10    69    1
Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry

Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
9    35    1
Characteristics of non-small-cell lung cancer with interstitial pneumonia: Variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia

Characteristics of non-small-cell lung cancer with interstitial pneumonia: Variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia
10    38    1
LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1

LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1
6    22    1
Molecular identification of an immunityand Ferroptosis-related gene signature in non-small cell lung Cancer

Molecular identification of an immunityand Ferroptosis-related gene signature in non-small cell lung Cancer
9    56    1
Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings

Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings
11    13    1
Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer

Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer
23    11    1
Development and validation of a risk model with variables related to non-small cell lung cancer in patients with pulmonary nodules: A retrospective study

Development and validation of a risk model with variables related to non-small cell lung cancer in patients with pulmonary nodules: A retrospective study
15    1    1
Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: Treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)

Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: Treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)
6    1    1